Status:
UNKNOWN
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.
Lead Sponsor:
Best Healthcare Inc.
Conditions:
Hepatitis A
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to evaluate the persistence of Hepatitis A antibody \~32 years post vaccination in healthy adults. The questions this study will answer are: 1) how long antibody per...
Eligibility Criteria
Inclusion
- Consent obtained
- Participated in original hepatitis A study in 1991
- No detectable hepatitis A antibody \~32 years after study start
Exclusion
- Receipt of any dose of hepatitis A vaccine other than the hepatitis A vaccine used in the initial studies
- History of hepatitis A
- Receipt of blood transfusion or blood products, including immunoglobulins, within the past 6 months.
- Receipt of any vaccine within the 14 days before receipt of the additional dose of hepatitis A vaccine or scheduled to receive any vaccine within 30 days after receipt of a booster dose of vaccine.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06184230
Start Date
January 1 2024
End Date
June 1 2025
Last Update
December 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.